Last update 08 May 2025

XH-S002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesCardiovascular Diseases
Active Indication
Ischemic Attack, TransientIschemic stroke
Inactive Indication-
Originator Organization
Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
Active Organization
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with XH-S002
CTR20233551
/ Not yet recruitingPhase 1
XH-S002 在健康成人受试者中单次和多次口服给药的安全性、耐受性和药代动力学特征及食物影响的Ⅰ期临床试验
[Translation] Phase I clinical trial of safety, tolerability, pharmacokinetic characteristics and food effects of single and multiple oral administration of XH-S002 in healthy adult subjects
NCT06204419
/ RecruitingPhase 1
A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of XH-S002 After Single Ascending Doses, Multiple Ascending Doses and Evaluation of Food Effects in Healthy Volunteers
100 Clinical Results associated with XH-S002
Login to view more data
100 Translational Medicine associated with XH-S002
Login to view more data
100 Patents (Medical) associated with XH-S002
Login to view more data
100 Deals associated with XH-S002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ischemic Attack, TransientPhase 1
China
Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
02 Nov 2023
Ischemic strokePhase 1
China
Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
02 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free